Clinical trial Recruiting at 1 site Interventional Ages 10 to 18

Remineralizing White Spot Lesions with P11-4: A three-arm trial

Official title: A Three-arm Randomized Controlled Trial Evaluating the Effectiveness of Self- Assembling Peptide P11-4 in the Remineralization of Enamel Carious White Spot Lesions

Run by Medical University of Warsaw · NCT07664046 · Data updated 2026-11-12

This trial tests whether applying the self-assembling peptide P11-4, alone or with fluoride varnish, can remineralize white spot lesions on permanent teeth in teens.

Quick facts

Study typeInterventional
Ages10 Years to 18 Years
SexAll
Enrollment75 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations1 site (Warsaw, Masovian Voivodeship)
StatusRecruiting
StartedFebruary 2, 2026
Main results expectedOctober 31, 2027
Study endsDecember 14, 2027
Registry record updatedJune 23, 2026
Trial IDNCT07664046 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Teens aged 10-18 with at least two active enamel carious white spot lesions on smooth surfaces of permanent teeth and no contraindications to fluoride.

Probably not a fit

Patients with lesions that do not respond to remineralization strategies or who have contraindications to fluoride may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, three-arm study enrolls participants aged 10-18 with active white spot lesions on smooth surfaces. Participants are assigned to receive either a single P11-4 application plus quarterly fluoride varnish, repeated P11-4 applications with quarterly fluoride varnish, or quarterly fluoride varnish alone. Remineralization is assessed over a one-year period using quantitative light-induced fluorescence and clinical exams. The trial is conducted at the Department of Pediatric Dentistry, Medical University of Warsaw, with follow-ups every three months. The primary goal is to determine changes in lesion mineral content and appearance over time.

Why it matters

Potential benefit: If successful, patients may experience improved remineralization of white spot lesions, potentially reducing the need for more invasive dental care.

How similar studies have gone: Previous studies suggest remineralization strategies with P11-4 show promise, but evidence for repeated applications is limited and this study adds new comparative data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age \>10 years and \<18 years.
2. Presence of at least 2 active enamel carious white spot lesions on a smooth tooth surface (labial/buccal surfaces of permanent teeth) based on International Caries Detection (ICDAS II) and Assessment System -Lesion Activity Assessment (ICDAS-LAA), and Lesion Activity Assessment (LAA criteria).
3. Tooth eligible for treatment:

   1. Vital pulp,
   2. no loss of hard dental tissues within the investigated lesion (ICDAS II) code 1 or 2 , LAA code 1, ICDAS-LAA\>7;
   3. QLF score parameters consistent with demineralization without loss of tissue continuity- code 1 or 2),
   4. no history of trauma to the tooth.
4. Systemically healthy patient.
5. No contraindications to the use of fluoride preparations.
6. No fixed orthodontic appliance.
7. Written consent for participation in the study signed by the legal guardian, or by the legal guardian and the patient.

Exclusion Criteria:

1. Systemic diseases or chronic medication use due to chronic conditions.
2. Viral/bacterial illness on the day of the visit, e.g., herpetic stomatitis, influenza, tonsillitis (temporary restriction).
3. Pregnancy or breastfeeding.
4. Allergy to any component of the SAP P11-4 preparation or the fluoride varnish.
5. Professional fluoride prophylaxis performed \<3 months ago.
6. Presence of cavitation (loss of hard tissues) in the treated tooth - ICDAS II code ≥3, ICDAS-LAA\<7, LAA code 0, 2-9.
7. Carious WSL previously treated with the Icon resin infiltrant (methacrylate resin).
8. Developmental enamel defects.
9. Patient undergoing orthodontic treatment with fixed appliances.
10. Inability to ensure regular follow-up visits.
11. Lack of cooperation from the guardian or the patient.
12. Refusal to participate in the study and/or absence of written consent.

Where it's running

  • University Clinical Center of the Medical University of Warsaw, Department of Pediatric Dentistry
    Warsaw, Masovian Voivodeship, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.